390.550000
401.100000
1
Please wait...
Please wait...
Please wait...
Please wait...
Please wait...
Please wait...
Please wait...
| Financial Year | Full AR | Chairman's Speech |
Director's Report |
Management Discussion |
Corporate Governance |
Auditor's Report |
Notes to Accounts |
|---|---|---|---|---|---|---|---|
| 2021 |
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
| 2018 |
|
|
|
|
|
|
|
| 2017 |
|
|
|
|
|
|
|
| 2016 |
|
|
|
|
|
|
|
| 2015 |
|
|
|
|
|
|
|
| 2014 |
|
|
|
|
|
|
|
| 2013 |
|
|
|
|
|
|
|
| 2012 |
|
|
|
|
|
|
|
| 2011 |
|
|
|
|
|
|
|
| 2010 |
|
|
|
|
|
|
|
| 2009 |
|
|
|
|
|
|
|
| 2008 |
|
|
|
|
|
|
|
| 2007 |
|
|
|
|
|
|
|
| 2006 |
|
|
|
|
|
|
|
| 2005 |
|
|
|
|
|
|
|
| 2004 |
|
|
|
|
|
|
|
| 2003 |
|
|
|
|
|
|
|
| 2002 |
|
|
|
|
|
|
|
| 2001 |
|
|
|
|
|
|
|
| 2000 |
|
|
|
|
|
|
|
| Time Period | Glenmark Pharma. | S&P BSE Healthcare | S&P BSE Mid Cap |
|---|---|---|---|
| YTD | -25.71 | -15.06 | -11.62 |
| 1 month | -16.09 | -9.88 | -10.82 |
| 3 months | -16.51 | -6.60 | -7.16 |
| 1 Year | -35.48 | -7.78 | 3.94 |
| 3 Years | -12.25 | 19.02 | 15.54 |
| 5 Years | -10.26 | 8.35 | 8.39 |
| 10 Years | 1.56 | 12.90 | 14.17 |
| Year | Glenmark Pharma. | S&P BSE Mid Cap | S&P BSE Healthcare |
|---|---|---|---|
| 2021 | 5.16 | 39.18 | 20.87 |
| 2020 | 42.75 | 19.87 | 61.45 |
| 2019 | -49.80 | -3.05 | -3.55 |
| 2018 | 16.26 | -13.31 | -5.89 |
| 2017 | -33.06 | 48.13 | 0.49 |
| 2016 | -3.82 | 7.97 | -12.88 |
| 2015 | 18.88 | 7.43 | 15.06 |
IPO update: Glenmark Life Sciences
now and be among the first to discover Stock Ideas